Skip to main content
. 2014 May 22;15(5):9160–9172. doi: 10.3390/ijms15059160

Figure 3.

Figure 3.

Immunohistochemical staining of PPARα (AC) and PPARγ (DF) in TSOD mice treated with 4-NQO. Representative slides show a strong increase in PPARα expression in the nuclei of lung proliferative lesions: (A,D): bronchioloalveolar hyperplasia; (B,E): adenoma; and (C,F): adenocarcinoma.